POM-V Prescription Required

Pyrocam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses

Active ingredient: Meloxicam

Form

Injection

Species

Cattle Horses Pigs

Manufacturer

Huvepharma NV

VMD MA No.

30282/3008

What it's used for

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating catt...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Pyrocam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical
signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with
antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness
and inflammation. For adjunctive therapy in the treatment of puerperal septicaemia
and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic
therapy.
Horses:
For use in the alleviation of inflammation and relief of pain in both acute and chronic
musculo-skeletal disorders.
For the relief of pain associated with equine colic.

For intramuscular use in pigs.
For intravenous use in horses.
Cattle:
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg
body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or
with oral re-hydration therapy, as appropriate.
Pigs:
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e.
2.0 ml/100 kg body weight) in combination with antibiotic therapy, as appropriate. If
required, a second administration of meloxicam can be given after 24 hours.
Horses:
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3.0
ml/100 kg body weight). For use in the alleviation of inflammation and the relief of
pain in both acute and chronic musculoskeletal disorders, an oral meloxicam product
may be used for continuation of treatment, 24 hours after administration of the
injection.
Avoid introduction of contamination during use.
The closure may be safely punctured 15 times. In order to prevent excessive
broaching of the stopper, a suitable multiple dosing device should be used.

Do not use in horses less than 6 weeks of age.
Do not use in pregnant or lactating mares.
Do not use in animals suffering from impaired hepatic, cardiac or renal function and
haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week
of age.

Cattle:
Common
(1 to 10 animals / 100 animals
treated):
Injection site swelling
(1)
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylactic-type reaction
(2)
(1) following subcutaneous administration, slight, transient
(2) may be serious (including fatal), should be treated symptomatically
Pigs:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylactic-type reaction
(3)

(3) may be serious (including fatal), should be treated symptomatically
Horses:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Injection site swelling
(4)
, anaphylactic-type
reaction
(5)

(4) transient, resolved without intervention
(5) may be serious (including fatal), should be treated symptomatically
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder <or its local representative> or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Treatment of calves with the veterinary medicinal product 20 minutes before
dehorning reduces post-operative pain. The veterinary medicinal product alone will
not provide adequate pain relief during the dehorning procedure. To obtain adequate
pain relief during surgery co-medication with an appropriate analgesic is needed.

Special precautions for safe use in the target species:
If adverse events occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which
require parenteral rehydration, as there may be a potential risk of renal toxicity.
In case of inadequate relief of pain when used in the treatment of equine colic,
careful re-evaluation of the diagnosis should be made as this could indicate the need
for surgical intervention.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
This veterinary medicinal product may cause hypersensitivity (allergic reactions).
People with known hypersensitivity to non-steroidal anti-inflammatory drugs
(NSAIDs) should avoid contact with the veterinary medicinal product.
This veterinary medicinal product can cause eye irritation. In case of contact with the
eyes, immediately rinse thoroughly with water.
Avoid dermal and oral exposure, including hand-to-mouth contact. Wash hands after
use.
Accidental self-injection may give rise to pain. Take precautions to avoid self-
injection. In case of accidental self-injection, seek medical advice immediately and
show the package leaflet or the label to the physician.
Meloxicam may have adverse effects on pregnancy and/or embryofoetal
development. This veterinary medicinal product should not be administered by
pregnant women or women attempting to conceive.
Special precautions for the protection of the environment:
Not applicable.

Do not administer concurrently with glucocorticosteroids, other NSAIDs or with
anticoagulant agents.

Store in the original package in order to protect from light.
This veterinary medicinal product does not require any special temperature storage
conditions.

Cattle:
Meat and offal: 15 days
Milk: 5 days (120 hours)
Pigs:
Meat and offal: 5 days
Horses:
Meat and offal: 5 days
Not authorised for use in horses producing milk for human consumption.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.